86732-32-3 Usage
Uses
Used in Pharmaceutical and Medicinal Chemistry:
2-Benzyl-tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione is utilized as a key intermediate in the synthesis of pharmaceutical compounds due to its potential biological activities. Its unique structure and the benzyl group facilitate the development of new drugs with improved efficacy and selectivity.
Used in Drug Development:
In the field of drug development, 2-Benzyl-tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione is employed as a starting material for the creation of novel therapeutic agents. The benzyl group's presence allows for structural modifications to enhance the compound's bioavailability and target specificity, which is crucial for the effectiveness of potential drugs.
Used in Medicinal Chemistry Research:
2-Benzyl-tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione serves as a subject of interest in medicinal chemistry research. Its cyclic structure and the possibility of structural modifications provide a foundation for in-depth studies aimed at uncovering new applications and understanding its interactions with biological systems.
Used in Drug Discovery:
In drug discovery, 2-Benzyl-tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione is used as a scaffold for the design of new molecular entities. Its unique structural features make it a valuable component in the search for innovative treatments and therapies across various medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 86732-32-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,7,3 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 86732-32:
(7*8)+(6*6)+(5*7)+(4*3)+(3*2)+(2*3)+(1*2)=153
153 % 10 = 3
So 86732-32-3 is a valid CAS Registry Number.
86732-32-3Relevant academic research and scientific papers
BICYCLIC AND BRIDGED NITROGEN HETEROCYCLES
-
Page/Page column 71, (2008/06/13)
Compounds are provided that act as potent modulators of one or more of the CCR1, CCR2 and CCR3 receptors. The compounds are generally fused-, spiro-or bridged-nitrogen heterocycles having an aryl and heteroaryl component and are useful in pharmaceutical compositions, methods for the treatment of CCR1-, CCR2-and/or CCR3-mediated diseases, and as controls in assays for the identification of competitive receptor antagonists for the above chemokine receptors.
PHENYLAMINOPYRIMIDINES AND THEIR USE AS RHO-KINASE INHIBITORS
-
Page column 52, (2010/02/06)
The invention relates to the phenylaminopyrimidines of formula (I), wherein A, D, R1, R2, R3 and R4 are defined as in the description. The invention also relates to methods for producing said phenylaminopyrimidines and to their use for producing drugs for the treatment and/or the prophylaxis of diseases, especially cardiovascular diseases.
Synthesis and Carbon-13 NMR Study of 2-Benzyl, 2-Methyl, 2-Aryloctahydropyrrolopyrroles and the 1,2,3,5-Tetrahydropyrrolopyrrole Ring System
Ohnmacht, Cyrus J.,Draper, Clyde W.,Dedinas, Robert F.,Loftus, Philip,Wong, J. J.
, p. 321 - 329 (2007/10/02)
2-Benzyl, 2-phenyl, 2-(3-methoxyphenyl) and 2-(3-trifluoromethylphenyl)octahydropyrrolopyrrole (9a, 9b, 9c and 9d, respectively) were prepared in five steps from 1-benzylpyrrole-3,4-dicarboxylic acid (2). 2-Methyloctahydropyrrolopyrrole (9'a
